How does EBRC.Z's PB Ratio compare to its peers?

EBRC.Z is good value based on its Price-To-Book Ratio (2.7x) compared to the peer average (3x).

How does EBRC.Z's PB Ratio compare vs other companies in the US Medical Equipment Industry?

EBRC.Z is expensive based on its Price-To-Book Ratio (2.7x) compared to the US Medical Equipment industry average (2.2x).

What is EBRC.Z's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate EBRC.Z's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of EBRC.Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate EBRC.Z's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

EBRC.Z Stock Overview

Develops implantable systems for wireless tissue stimulation. More details

EBRC.Z fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	2/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Revenue is forecast to grow 138.5% per year

Risk Analysis

Earnings are forecast to decline by an average of 9.8% per year for the next 3 years

Makes less than USD$1m in revenue ($0)

Shares are highly illiquid

Shareholders have been diluted in the past year

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

EBR Systems, Inc. Competitors

Sensus Healthcare

NasdaqCM:SRTS

US$116.4m

Zomedica

NYSEAM:ZOM

US$122.8m

Jin Medical International

NasdaqCM:ZJYL

US$134.6m

Nevro

NYSE:NVRO

US$142.0m

Price History & Performance

Summary of share price highs, lows and changes for EBR Systems
Historical stock prices
Current Share Price	AU$0.55
52 Week High	AU$0.55
52 Week Low	AU$0.32
Beta	1.0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	70.75%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	70.75%

Recent updates

Shareholder Returns

	EBRC.Z	US Medical Equipment	US Market
7D	0%	-1.5%	-2.4%
1Y	70.7%	10.0%	23.4%

Return vs Industry: EBRC.Z exceeded the US Medical Equipment industry which returned -1.8% over the past year.

Return vs Market: EBRC.Z exceeded the US Market which returned 15.2% over the past year.

Price Volatility

Is EBRC.Z's price volatile compared to industry and market?
EBRC.Z volatility
EBRC.Z Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: EBRC.Z has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EBRC.Z's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2003	n/a	John McCutcheon	ebrsystemsinc.com

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning.

EBR Systems, Inc. Fundamentals Summary

How do EBR Systems's earnings and revenue compare to its market cap?
EBRC.Z fundamental statistics
Market cap	US$120.66m
Earnings (TTM)	-US$33.04m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-3.6x

P/E Ratio

Is EBRC.Z overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EBRC.Z income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$33.04m
Earnings	-US$33.04m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.11
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	88.3%

How did EBRC.Z perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/11/28 20:51
End of Day Share Price	2023/08/31 00:00
Earnings	2023/06/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EBR Systems, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Russell Wright	Barclay Pearce Capital Pty Limited
John Hester	Bell Potter
Martyn Jacobs	Bell Potter